BALCAROVÁ, Zdeňka, Jana KAŠPÁRKOVÁ, Alena ŽÁKOVSKÁ, Olga NOVÁKOVÁ, Maria F. SIVO, Giovanni NATILE and Viktor BRABEC. DNA interactions of a novel platinum drug, cis-[PtCl(NH3)(2)(N7-acyclovir)]. MOLECULAR PHARMACOLOGY. 1998, vol. 53, No 5, 10 pp. ISSN 0026-895X.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name DNA interactions of a novel platinum drug, cis-[PtCl(NH3)(2)(N7-acyclovir)]
Authors BALCAROVÁ, Zdeňka (203 Czech Republic), Jana KAŠPÁRKOVÁ (203 Czech Republic), Alena ŽÁKOVSKÁ (203 Czech Republic), Olga NOVÁKOVÁ (203 Czech Republic), Maria F. SIVO (380 Italy), Giovanni NATILE (380 Italy) and Viktor BRABEC (203 Czech Republic, guarantor).
Edition MOLECULAR PHARMACOLOGY, 1998, 0026-895X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 5.428
Organization unit Faculty of Science
Keywords in English INTERSTRAND CROSS-LINKS; ANTITUMOR AGENTS; CELL-DEATH; COMPLEXES; CIS-DIAMMINEDICHLOROPLATINUM(II); ADDUCTS; FLUORESCENCE; CISPLATIN; TRANS-DIAMMINEDICHLOROPLATINUM(II); APOPTOSIS
Changed by Changed by: RNDr. Kamila Neplechová, Ph.D., učo 70207. Changed: 5/8/2010 14:00.
Abstract
We synthesized a novel platinum drug, cis-[PtCl(NH3)(2)(N7-ACV)](+), in which ACV is the antiviral drug acyclovir [a deoxyriboguanosine analogue, 9-(2-hydroxyethoxymethyl)guanine]. This new compound exhibits antiviral efficacy in vitro and exhibits an antitumor activity profile different from that of cisplatin. To contribute to understanding the mechanisms underlying biological activity of this new compound, we studied modifications of natural and synthetic DNAs in cell-free media by cis-[PtCl(NH3)(2)(N7-ACV)](+) by various biochemical and biophysical methods.
Links
GA204/97/P028, research and development projectName: Biofyzikální analýza vlivu protinádorově účinných komplexů ruthenia na DNA
PrintDisplayed: 6/10/2024 10:27